Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer

BACKGROUND: Receptor tyrosine kinases promote tumor progression in many cancers, although oncologic activation differs between diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC). Fibroblast growth factor receptor (FGFR) is one RTK, and we previously reported the clinical sign...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Surg Oncol
Päätekijät: Inokuchi, Mikito, Murase, Hideaki, Otsuki, Sho, Kawano, Tatsuyuki, Kojima, Kazuyuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217622/
https://ncbi.nlm.nih.gov/pubmed/28056982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1081-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia